Of interest, following collection of the data presented in this paper, in an additional case not included in the cohort presented, the NWGLH conducted genetic testing for a known familial pathogenic BRCA1 variant in an FFPE sample (non-neoplastic tissue) from a deceased individual diagnosed with breast cancer in her 80s. The gene discussed is BRCA1; the disease is breast carcinoma.